16565551

Source:http://linkedlifedata.com/resource/pubmed/id/16565551

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0007193, umls-concept:C0033325, umls-concept:C0038952, umls-concept:C0439234, umls-concept:C0443252
pubmed:issue	4
pubmed:dateCreated	2006-3-27
pubmed:abstractText	Because of their favorable prognostic effects, angiotensin converting enzyme inhibitors (ACEI), angiotensin II receptor blockers (ARB) and beta blockers have become background therapy in dilated cardiomyopathy (DCM). However, there are few reports concerning the long-term prognosis of Japanese patients with DCM in relation to these treatments.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/101137683
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic beta-Antagonists, http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin II Type 1 Receptor..., http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin-Converting Enzyme..., http://linkedlifedata.com/resource/pubmed/chemical/Anti-Arrhythmia Agents
pubmed:status	MEDLINE
pubmed:month	Apr
pubmed:issn	1346-9843
pubmed:author	pubmed-author:BabaYuichiY, pubmed-author:DoiYoshinoriY, pubmed-author:FurunoTakashiT, pubmed-author:HamadaTomoyukiT, pubmed-author:HitomiNobuhikoN, pubmed-author:HoshikawaEriE, pubmed-author:KitaokaHiroakiH, pubmed-author:KuboToruT, pubmed-author:MatsumuraYoshihisaY, pubmed-author:NishinagaMasanoriM, pubmed-author:OkawaMakotoM, pubmed-author:SatoKyokoK, pubmed-author:TakuwaYohY, pubmed-author:YabeToshikazuT, pubmed-author:YamasakiNaohitoN
pubmed:issnType	Print
pubmed:volume	70
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	376-83
pubmed:meshHeading	pubmed-meshheading:16565551-Adrenergic beta-Antagonists, pubmed-meshheading:16565551-Adult, pubmed-meshheading:16565551-Aged, pubmed-meshheading:16565551-Aged, 80 and over, pubmed-meshheading:16565551-Angiotensin II Type 1 Receptor Blockers, pubmed-meshheading:16565551-Angiotensin-Converting Enzyme Inhibitors, pubmed-meshheading:16565551-Anti-Arrhythmia Agents, pubmed-meshheading:16565551-Cardiomyopathy, Dilated, pubmed-meshheading:16565551-Data Interpretation, Statistical, pubmed-meshheading:16565551-Death, pubmed-meshheading:16565551-Female, pubmed-meshheading:16565551-Humans, pubmed-meshheading:16565551-Japan, pubmed-meshheading:16565551-Longitudinal Studies, pubmed-meshheading:16565551-Male, pubmed-meshheading:16565551-Middle Aged, pubmed-meshheading:16565551-Prognosis, pubmed-meshheading:16565551-Retrospective Studies, pubmed-meshheading:16565551-Survival Rate
pubmed:year	2006
pubmed:articleTitle	Long-term prognosis of dilated cardiomyopathy revisited: an improvement in survival over the past 20 years.
pubmed:affiliation	Department of Medicine and Geriatrics, Kochi Medical School, Kochi University, Nankoku-shi, Japan.
pubmed:publicationType	Journal Article